Chitosan monomer promotes tissue regeneration on dental pulp wounds

Tsunenori Matsunaga, Kajiro Yanagiguchi, Shizuka Yamada, Naoko Ohara, Takeshi Ikeda, Yoshihiko Hayashi

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The present study was undertaken to evaluate the applicability of chitosan monomer (D-glucosamine hydrochloride) as a pulp capping medicament. Both in vitro and in vivo experiments were carried out to study the cell metabolism and wound healing mechanisms following the application of chitomonosaccharide. After 3 days of osteoblast culture, alkaline phosphatase (ALP) activity significantly increased in the chitosan group. Reverse transcription polymerase chain reaction analysis revealed that chitosan induced an increase in the expression of ALP mRNA after 3 days and bone morphogenetic protein-2 mRNA after 7 days of osteoblast incubation. Inflammatory cytokine, interleukin (IL)-8, synthesis in fibroblasts was strongly suppressed in the medium supplemented with chitosan monomer. Histopathological effects were evaluated in rat experiments. After 1 day, inflammatory cell infiltrations were observed to be weak when compared with the application of chitosan polymer. After 3 days, a remarkable proliferation of fibroblasts was seen near the applied chitosan monomer. The inflammatory cell infiltration had almost completely disappeared. After 5 days, the fibroblastic proliferation progressed, and some odontoblastic cells appeared at the periphery of the proliferated fibroblasts. These findings indicate that the present study is the first report that chitosan monomer acts as a biocompatibly stable medicament even at the initial stage of wound healing in comparison with the application of chitosan polymer.

Original languageEnglish
Pages (from-to)711-720
Number of pages10
JournalJournal of Biomedical Materials Research - Part A
Volume76
Issue number4
DOIs
Publication statusPublished - Mar 2006
Externally publishedYes

Fingerprint

Tissue regeneration
Chitosan
Pulp
Monomers
Fibroblasts
Osteoblasts
Phosphatases
Infiltration
Alkaline Phosphatase
Polymers
Glucosamine
Bone Morphogenetic Protein 2
Messenger RNA
Polymerase chain reaction
Transcription
Interleukin-8
Cell culture
Metabolism
Rats
Bone

Keywords

  • Alkaline phosphatase activity
  • D-glucosamine hydrochloride
  • Direct pulp capping
  • Tissue regeneration
  • Wound healing

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Chitosan monomer promotes tissue regeneration on dental pulp wounds. / Matsunaga, Tsunenori; Yanagiguchi, Kajiro; Yamada, Shizuka; Ohara, Naoko; Ikeda, Takeshi; Hayashi, Yoshihiko.

In: Journal of Biomedical Materials Research - Part A, Vol. 76, No. 4, 03.2006, p. 711-720.

Research output: Contribution to journalArticle

Matsunaga, Tsunenori ; Yanagiguchi, Kajiro ; Yamada, Shizuka ; Ohara, Naoko ; Ikeda, Takeshi ; Hayashi, Yoshihiko. / Chitosan monomer promotes tissue regeneration on dental pulp wounds. In: Journal of Biomedical Materials Research - Part A. 2006 ; Vol. 76, No. 4. pp. 711-720.
@article{cfec11eb2f2049ccb49a673a99662f0a,
title = "Chitosan monomer promotes tissue regeneration on dental pulp wounds",
abstract = "The present study was undertaken to evaluate the applicability of chitosan monomer (D-glucosamine hydrochloride) as a pulp capping medicament. Both in vitro and in vivo experiments were carried out to study the cell metabolism and wound healing mechanisms following the application of chitomonosaccharide. After 3 days of osteoblast culture, alkaline phosphatase (ALP) activity significantly increased in the chitosan group. Reverse transcription polymerase chain reaction analysis revealed that chitosan induced an increase in the expression of ALP mRNA after 3 days and bone morphogenetic protein-2 mRNA after 7 days of osteoblast incubation. Inflammatory cytokine, interleukin (IL)-8, synthesis in fibroblasts was strongly suppressed in the medium supplemented with chitosan monomer. Histopathological effects were evaluated in rat experiments. After 1 day, inflammatory cell infiltrations were observed to be weak when compared with the application of chitosan polymer. After 3 days, a remarkable proliferation of fibroblasts was seen near the applied chitosan monomer. The inflammatory cell infiltration had almost completely disappeared. After 5 days, the fibroblastic proliferation progressed, and some odontoblastic cells appeared at the periphery of the proliferated fibroblasts. These findings indicate that the present study is the first report that chitosan monomer acts as a biocompatibly stable medicament even at the initial stage of wound healing in comparison with the application of chitosan polymer.",
keywords = "Alkaline phosphatase activity, D-glucosamine hydrochloride, Direct pulp capping, Tissue regeneration, Wound healing",
author = "Tsunenori Matsunaga and Kajiro Yanagiguchi and Shizuka Yamada and Naoko Ohara and Takeshi Ikeda and Yoshihiko Hayashi",
year = "2006",
month = "3",
doi = "10.1002/jbm.a.30588",
language = "English",
volume = "76",
pages = "711--720",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Chitosan monomer promotes tissue regeneration on dental pulp wounds

AU - Matsunaga, Tsunenori

AU - Yanagiguchi, Kajiro

AU - Yamada, Shizuka

AU - Ohara, Naoko

AU - Ikeda, Takeshi

AU - Hayashi, Yoshihiko

PY - 2006/3

Y1 - 2006/3

N2 - The present study was undertaken to evaluate the applicability of chitosan monomer (D-glucosamine hydrochloride) as a pulp capping medicament. Both in vitro and in vivo experiments were carried out to study the cell metabolism and wound healing mechanisms following the application of chitomonosaccharide. After 3 days of osteoblast culture, alkaline phosphatase (ALP) activity significantly increased in the chitosan group. Reverse transcription polymerase chain reaction analysis revealed that chitosan induced an increase in the expression of ALP mRNA after 3 days and bone morphogenetic protein-2 mRNA after 7 days of osteoblast incubation. Inflammatory cytokine, interleukin (IL)-8, synthesis in fibroblasts was strongly suppressed in the medium supplemented with chitosan monomer. Histopathological effects were evaluated in rat experiments. After 1 day, inflammatory cell infiltrations were observed to be weak when compared with the application of chitosan polymer. After 3 days, a remarkable proliferation of fibroblasts was seen near the applied chitosan monomer. The inflammatory cell infiltration had almost completely disappeared. After 5 days, the fibroblastic proliferation progressed, and some odontoblastic cells appeared at the periphery of the proliferated fibroblasts. These findings indicate that the present study is the first report that chitosan monomer acts as a biocompatibly stable medicament even at the initial stage of wound healing in comparison with the application of chitosan polymer.

AB - The present study was undertaken to evaluate the applicability of chitosan monomer (D-glucosamine hydrochloride) as a pulp capping medicament. Both in vitro and in vivo experiments were carried out to study the cell metabolism and wound healing mechanisms following the application of chitomonosaccharide. After 3 days of osteoblast culture, alkaline phosphatase (ALP) activity significantly increased in the chitosan group. Reverse transcription polymerase chain reaction analysis revealed that chitosan induced an increase in the expression of ALP mRNA after 3 days and bone morphogenetic protein-2 mRNA after 7 days of osteoblast incubation. Inflammatory cytokine, interleukin (IL)-8, synthesis in fibroblasts was strongly suppressed in the medium supplemented with chitosan monomer. Histopathological effects were evaluated in rat experiments. After 1 day, inflammatory cell infiltrations were observed to be weak when compared with the application of chitosan polymer. After 3 days, a remarkable proliferation of fibroblasts was seen near the applied chitosan monomer. The inflammatory cell infiltration had almost completely disappeared. After 5 days, the fibroblastic proliferation progressed, and some odontoblastic cells appeared at the periphery of the proliferated fibroblasts. These findings indicate that the present study is the first report that chitosan monomer acts as a biocompatibly stable medicament even at the initial stage of wound healing in comparison with the application of chitosan polymer.

KW - Alkaline phosphatase activity

KW - D-glucosamine hydrochloride

KW - Direct pulp capping

KW - Tissue regeneration

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=33745530253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745530253&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.30588

DO - 10.1002/jbm.a.30588

M3 - Article

C2 - 16315192

AN - SCOPUS:33745530253

VL - 76

SP - 711

EP - 720

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 4

ER -